Precision medicine starts here
|18th May 2018
Precision medicine is set to revolutionise the healthcare sector, promising vastly improved outcomes for patients. However, as treatments become more precise, pharma companies will need to create more targeted commercial strategies. Meanwhile, the clinical trial recruitment process will become more challenging and a new series of stakeholders will emerge. These are just some of the barriers.
That’s why have dedicated the latest edition of our ‘Perspective’ magazine to this complex topic. We have combined the views of our in-house precision medicine experts and voices from key industry leaders to give you the latest information on the trend set to redefine healthcare as we know it – precision medicine.
In this edition of ‘Perspective’, we answer the following questions:
- Are we ready for precision medicine?
- How can you master the precision medicine opportunity?
- How can industry drive greater engagement in the clinical trial recruitment process?
- Will precision medicine change the way we interact with patients?
- Who are the new healthcare influencers?
Our content has moved
|18th November 2020
We’re posting all new articles on our parent website fishawack.com
Fishawack Health launches Delta Magazine
|17th November 2020
Our parent company Fishawack Health has launched a new magazine with a first issue unpacking rare disease.
In the precision medicine era, the line between products and services is blurred
|27th August 2020
Precision and personalised medicines are more than products, they are services in their own right. So, how should pharma approach this uncharted territory to ensure targeted therapies work for patients?